Epcoritamab (ROR 11.15, PRR 11.11), a CD3×CD20 bispecific T-cell engager distinct from anti-CD20 mAbs, currently does not carry a PML warning in its SPC. The gene discussed is LINC-ROR; the disease is progressive multifocal leukoencephalopathy.